Branch TIBS 23:45-50 Feb. 1998. |
Agrawal et al., 1991. Pharmacokinetics, biodistribution, and stability of igodeoxynucleotide phosphorothioates in mice. Proc. Natl. Acad. Sci. USA, 88:7595. |
Agrawal, 1996. Antisense oligonucleotides: towards clinical trials, Tibtech, 14:376. |
Beeri et al., 1995. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Current Biology, 5:1063-1071. |
Ben Aziz-Aloya et al., 1993. Expression of a human acetylcholinesterase promoter-reporter construct in developing neuromuscular junctions of Xenopus embryos, Proc. Natl. Acad. Sci. USA, 90:2471-2475. |
Betz et al., 1994, Basic Neurochem. Molecular Cell, (Raven Press Ltd, NY) 5th Ed., 681-699. |
Birikh et al, 1997. Probing Accessible Sites for Ribozymes on Human Acetylcholinesterase RNA, RNA Apr., 1997 pp. 429-437. |
Brem et al., 1993. Polymers as controlled drug delivery devised for the treatment of malignant brain tumors, Eur. J. Pharm. Biopharm 39:2-7. |
Bickel, et al., 1993. Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery, Proc. Natl. Acad. Sci. USA 90(7)2618-2622. |
Calabretta, et al, 1996. Antisense strategies in the treatment of leukemias, Semin. Oncol., 23:78. |
Crooke, 1995. Progress in antisense therapeutics, Hematol. Pathol., 2:59. [*n/a--will mail in]. |
Darboux, et al., 1996. The structure-function relationships in Drosophila neurotactin shows that cholinesterasic domains may have adhesive properties, EMBRO J., 15:4835-4843. |
Ehrlich et al., 1994. Use of partially phosphorothioated "Antisense" oligodeoxynucleotides for sequence-dependent modulation of hematopoiesis. Antisense Res. Develop., 4:173-183. |
Galileo et al., 1991. J. Cell. Biol., 112:1285. [*n/a--will mail in]. |
Gewirtz, 1993. Oligodeoxynucleotide-based therapeutics for human leukemias, Stem Cells Dayt., 11:96. |
Grifman et al., 1995. Impairment of neurite extension and apoptosis-dependent DNA fragmentation in primary neuronal cell cultures administered with an ACHE antisense oligonucleotide (Abstract) J. Neurochem., 65 (supplement) S82D. |
Grifman et al., 1997. Potential antisense oligonucleotide therapies for neurodegenerative diseases. In Concepts in Gene Therapy, M. Strauss and J.A. Barranger, eds. (Walter de Gruyter & Co., Berlin). |
Hanania, et al 1995. Recent advances in the application of gene therapy to human disease, Am. J. Med., 99:537. |
Jones et al., 1995. The effect of acetylcholinesterase on outgrowth of dopaminergic neurons in organotypic slice culture of rat midbrain, Cell Tissue Res., 2679:323-330. |
Karpel et al. 1994. Expression of three alternative acetylcholinesterase messenger RNAs in human tumor cell lines of different tissue origins, Exptl. Cell. Res. 210:268-277. |
Karpel et al, 1996. Overexpression of alternative human acetylcholinesterase forms modulates process extensions in cultured glioma cells, J. Neurochem. 66:114-123. |
Knapp et al., 1994. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA, 271:985-991. |
Lapidot-Lifson, et al, 1992. Cloning and antisense oligodeoxynucleotide inhibition of a human homolog of cdc2 required in hematopoiesis, Proc. Natl. Acad. Sci. USA, 89:579. |
Layer, 1995. Non-classical roles of cholinesterases in the embryonic brain and possible links to Alzheimer disease, Alzheimer Disease adn associated disorders, 9:29. |
Lefebvre-D'Hellencourt, et al, 1995. Immunomodulation by cytokine antisense oligonucleotides, Eur. Cytokine Netw., 6:7. [*n/a--will mail in]. |
Legay et al. 1993a. Cloning and expression of a rat acetylcholinesterase subunit: generation of multiple molecular forms, complementarity with a Torpedo collagenic subunit, J. Neurochem. 60:337-346. |
Legay et al. 1993b. Expression of a cDNA encoding the glycolipid-anchored form of rat acetylcholinesterase, FEBS Lett 315:163-166. |
Lev-Lehman et al., 1994. Antisense inhibition of acetylcholinesterase gene expression causes transient hematopoietic alterations in vivo. Gene Therapy, 1:127-135. |
Lev-Lehman et al., 1997. Antisense Oligomers in vitro and in vivo. In Antisense Therapeutics, A. Cohen and S. Smicek, eds (Plenum Press, New York). |
Li et al., 1991. Gene structure of mammalian acetylcholinesterase: Alternative exons dictate tissue specific expression, J. Biol. Chem. 266:23083-23090. |
Li et al., 1993. Tissue-specific Expression and Alternative mRNA Processing of the Mammalian Acetylcholinesterase Gene, J. Biol. Chem. 268:5790-97. |
Morrison, R. 1992. Neuroscience Facts 3:3. [*n/a--will mail in]. |
Pardridge, et al., 1992. Blood-brain barrier and new approaches to brain drug delivery. West J. Med. 156(3):281-286. |
Pardridge, 1992. Recent Developments in peptide drug delivery to the brain, Pharm. Toxicol. 71(1):3-10. |
Patinkin, et al., 1994. Antisense inhibition of butyrylcholinesterase gene expression predicts adverse hematopoietic consequences to cholinesterase inhibitors, Cell. Mol. Neurobiol., 14:459. |
Rosolen et al., 1990. Antisense Inhibition of Single Copy N-myc Expression Results in Decreased Cell Growth without Reduction of c-myc Protein in a Neuroepittelioma Cell Line, Cancer Res., 50:6316. |
Scanlon, et al., 1995. Oligonucleotides-mediated modulation of mammalian gene expression, FASEB J., 9:1288. |
Small, et al., 1995. Cholinergic regulation of neurite outgrowth from isolated chick sympathetic neurons in culture, J. Neurosci., 15:144-151. |
Soreq, et al., 1994. Antisense oligonucleotide inhibition of acetylcholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo, Proc. Natl. Acad. Sci. USA, 91:7907-7911. |
Stein and Cheng, 1993. Antisense oligonucleotides as therapeutic agents--Is the bullet really magical? Science, 261:1004. |
Sternfield, et al., 1997. Catalytic and non-catalytic acetylcholinesterase functions implied from transgenic ACHE expression in vertebrates. In Neurotransmitter Release and Uptake, S. Pogun ed. (Springer-Verlag, Berlin). |
Wagner, 1994. Gene inhibition using antisense oligodeoxynucleotides, Nature, 372:333. |
Winstein et al., 1991. J. Cell Biol., 112:1205. [*n/a--will mail in]. |
Chalazonitis, A., Kessler JA, Twardzik DR, Morrison RS, 1992. Neuroscience Facts 3:3. (Originally cited under Morrison, J. Abstract only submitted at this time. Full article to follow). |
Crooke, 1995. Progress in antisense therapeutics, Hematol. Pathol., 2:59. |
Galileo et al., 1992. Retrovirally Introduced Antisense Integrin RNA Inhibits Neuroblast Migration In Vivo J. Cell. Biol., 112:1285. (Originally improperly cited as 1991). |
Lefebvre-D'Hellencourt, et al, 1995. Immunomodulation by cytokine antisense oligonucleotides, Eur. Cytokine Netw., 6:7. |
Winstein et al., 1991. J. Cell. Biol., 112:1205. (Will submit when available). |